Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| COP9 Signalosome Complex | 2 | 2018 | 3 | 0.94 | Why? |
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 334 | 0.75 | Why? |
| RNA, Neoplasm | 1 | 2018 | 34 | 0.74 | Why? |
| Rhabdomyosarcoma | 1 | 2017 | 15 | 0.71 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.65 | Why? |
| Triple Negative Breast Neoplasms | 1 | 2017 | 92 | 0.62 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.55 | Why? |
| Peptide Hydrolases | 2 | 2018 | 1269 | 0.51 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.49 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.47 | Why? |
| DNA | 1 | 2017 | 778 | 0.45 | Why? |
| Breast Neoplasms | 3 | 2018 | 3633 | 0.44 | Why? |
| Thioredoxins | 2 | 2018 | 25 | 0.36 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.35 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.30 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.29 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.27 | Why? |
| Lymphocyte Subsets | 2 | 2021 | 987 | 0.27 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.26 | Why? |
| Heterografts | 2 | 2018 | 203 | 0.22 | Why? |
| Leukemia, Myeloid, Acute | 2 | 2018 | 676 | 0.22 | Why? |
| CD4-CD8 Ratio | 1 | 2021 | 235 | 0.21 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.21 | Why? |
| Peroxiredoxins | 1 | 2018 | 13 | 0.20 | Why? |
| Neoplasm Transplantation | 1 | 2018 | 55 | 0.19 | Why? |
| Leukapheresis | 1 | 2018 | 20 | 0.18 | Why? |
| Cadherins | 1 | 2018 | 145 | 0.18 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.17 | Why? |
| Leukemia, Monocytic, Acute | 1 | 2017 | 8 | 0.17 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.17 | Why? |
| Mastectomy, Segmental | 1 | 2017 | 124 | 0.17 | Why? |
| Transforming Growth Factor beta | 1 | 2018 | 363 | 0.15 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2018 | 242 | 0.15 | Why? |
| Leukocytosis | 1 | 2018 | 280 | 0.15 | Why? |
| Reactive Oxygen Species | 2 | 2018 | 1136 | 0.15 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.14 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.13 | Why? |
| Interleukin-10 | 1 | 2021 | 1409 | 0.13 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1014 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.13 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.13 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.12 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.12 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.11 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.11 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Cities | 1 | 2020 | 4937 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.09 | Why? |
| Female | 14 | 2021 | 380317 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Aged | 9 | 2021 | 215776 | 0.08 | Why? |
| Cell Proliferation | 3 | 2018 | 1973 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.07 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.07 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.07 | Why? |
| Mice | 3 | 2018 | 21357 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.06 | Why? |
| Humans | 17 | 2021 | 930598 | 0.06 | Why? |
| Drugs, Chinese Herbal | 1 | 2018 | 2760 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Transaminases | 1 | 2020 | 152 | 0.05 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
| Larynx | 1 | 2020 | 126 | 0.05 | Why? |
| HL-60 Cells | 1 | 2018 | 60 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| U937 Cells | 1 | 2018 | 77 | 0.05 | Why? |
| Blood Coagulation Factors | 1 | 2021 | 223 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Serum Amyloid A Protein | 1 | 2020 | 211 | 0.05 | Why? |
| China | 3 | 2020 | 50654 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.05 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.05 | Why? |
| Mice, SCID | 1 | 2018 | 225 | 0.05 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.04 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.03 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
| Animals | 3 | 2018 | 78931 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2021 | 2328 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Aging | 1 | 2021 | 3581 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
Pan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(86)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_